Company intelligence / Profile preview

BioMed Valley Discoveries

Kansas City, Missouri, United Statesbiomed-valley.com ↗
Ownership
Private
Development stage
Phase 2
01

Overview

BioMed Valley Discoveries is a private, clinical-stage biotechnology company focused on developing therapies for difficult-to-treat diseases—primarily oncology—by advancing early-stage assets through proof-of-concept before seeking partners for later development. Its lead asset has been ulixertinib, an ERK inhibitor targeting the MAPK pathway. The company leverages stable funding from the Stowers Institute to pursue high-risk/high-reward translational science that may be overlooked by traditional investors. As of recent data, no active interventional trials are listed publicly.

Therapeutic areas
OncologyRare Diseases
Modalities
Small molecules (notably ERK inhibitors such as ulixertinib/BVD-523)Potentially others in oncology and immuno-oncology (details limited)
Industry
Biotech
02

Drug pipeline

4 assets

ulixertinib

2

3 more assets in the full pipeline.

Request access →
03

Partnerships

Collaborates with academic and clinical institutions globally for early-stage development; seeks out-license partners post-proof-of-concept but no specific major pharma partnerships named publicly.

Beyond the preview

Go deeper on BioMed Valley Discoveries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioMed Valley Discoveries.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call